Sr. Director, Scientific Communications Publications

Summit, NJ, US
Aug 11, 2018
Required Education
Position Type
Full time
Other Locations:US- NJ- Summit East


Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.


Senior Director, Early Pipeline Medical Communications


Executive Director, Global Scientific Communications


Corporate Medical Affairs
  • Scientific or Medical Graduate Level Degree (MS, Pharm D, PhD, MD) required
  • Minimum 5-7 years of pharmaceutical industry-based publication planning required
  • People management experience required
  • Experience with early phase research and/or medical communication channels, including medical congress booth planning preferred

Position Summary

The Senior Director, Early Pipeline Medical Communications serves as the strategic lead for all Celgene medical communications related to market access research, as well as, basic research, translational, and early pipeline compounds. The role is principally charged with supervising a team of communication professionals to develop scientific platforms, strategic publication plans, publication tactics, and external communication tools to ensure external dissemination of science and evidence to support early compounds throughout the development. Internal awareness tools via medical slides and other communication vehicles will also be a principal accountability for this role, as is accountability for the medical booth at scientific congresses. This role is directly involved with ensuring alliances and joint ventures are established and managed appropriately with regard to scientific and medical communications, ranging from the joint venture agreement to publication development, review and approval. A key success factor for this role is the ability to liaise effectively with matrix partners toward strong early collaboration on evidence generation projects that are intended for external dissemination. Toward this objective, the Senior Director, Early Pipeline Communications builds strong collaborations with multiple matrix partners, including leadership of Early Commercialization, Global Medical Affairs, Clinical Research, Translational Medicine, Alliance Management, Thematic Centers of Excellence (TCoE) Leads and Project Leadership divisions. This position supports all Celgene franchises, including hematology, oncology, inflammation and immunology.

Core Responsibilities
  • Develops relationships with key stakeholders across early development, translational, and research teams; liaise appropriately with franchise teams to ensure alignment.
  • Identifies strategic communication priorities and platforms based on Celgene's early pipeline research programs
  • Supports communication of investigational research across Celgene's Thematic Centers of Excellence (TCoE's)
  • Supervises the development of scientific strategic platforms to ensure consistency and clarity of scientific messages across early pipeline communications. Ensures implementation across matrix functions and capabilities.
  • Drives innovation in the development of innovative tools for the external communication of our early portfolio of research and compounds via slides and other channels, as appropriate.
  • Supervises the development of key external facing communication tools including medical booth panels at scientific congresses and the website.
  • Ensures internal awareness of pipeline agents by liaising with stakeholders for development of internal training and education materials
  • Champions the development of novel pipeline communication tools and vehicles to ensure appropriate visibility by stakeholders
  • Supervises the development of publication plans for pipeline agents; final approves publication deliverables in alignment with corresponding summary of procedure (SOP) documents
  • Maintains strong awareness of current guidance and regulation related to external dissemination of medical information to customers; trains matrix stakeholders in processes, as required
  • Establishes and shares best practices across Corporate Medical Affairs and corresponding stakeholder functions.
  • Develops close relationships with Alliance Management to ensure appropriate and timely review of Alliance partner publications, publication strategy, and overall awareness of timing of key publication events with external partners. Participates as a contributor to the joint venture agreement to ensure scientific communications are developed appropriately and in the interests of supporting Celgene strategic objectives. Ensures all elements of agreement are implemented. Serves as visible strategic leader for publications arising from alliance arrangements working in collaboration with project and franchise leadership.
  • Maintains a deep understanding of disease states and science in order to serve as a strong partner for matrix teams and stakeholders
  • Manages annual budget and vendors, appropriately utilizing allocated resources for value creation and impact.
  • Develops a high performing team focused on enterprise alignment, consistent scientific messaging, focus on impact, and delivery via innovative channels.
  • Recruits, develops, and integrates direct reports, supporting their success within the broader Celgene organization
  • Performs other responsibilities as requested by management

Other Responsibilities
  • Conducts business in accordance with Celgene Values. Completes all assigned SOPs and training within designated timeframe and adheres to job-specific SOPs and work instructions
  • Identifies and reports any adverse events (AEs) in accordance with Corporate policy and procedures
  • Assists in the overall training of new Scientific Communications personnel and ensures key activities are incorporated as part of the training
  • Attends external meetings and professional education seminars, as appropriate, to enhance knowledge
  • Dedicated to continuous learning to broaden therapeutic area knowledge and pharmaceutical industry acumen

Skills/Knowledge Required
  • Ability to conceptually organize and analyze data, interpret, and synthesize complex clinical and non-clinical statistical reports to derive key outcomes and messages; ability to translate scientific and technical issues for diverse audiences
  • Experience or background in working within the pharmaceutical industry, strong awareness of compliance issues and guidelines around medical education and publications
  • Ability to work with multidisciplinary teams to ensure execution of deliverable successfully
  • Excellent written, verbal and interpersonal communication skills
  • Flexible, with positive attitude, strong ability to multi task, prioritize projects effectively and proactively collaborate and communicate at all levels within the company
  • Experience with innovative tools and electronic communication channels; knowledge of applicable guidance related to the dissemination of scientific evidence to external customers
  • Strong leadership capability with a focus on development of high performing, integrated teams
  • Some travel required to represent company at medical conferences, presentations, and other meetings

New 4/2018

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.